Literature DB >> 18629644

Inhibitory effects of short-chain fatty acids on matrix metalloproteinase secretion from human colonic subepithelial myofibroblasts.

Takato Kawamura1, Akira Andoh, Atsushi Nishida, Makoto Shioya, Yuhki Yagi, Takashi Nishimura, Takayoshi Hashimoto, Tomoyuki Tsujikawa, Hiroyuki Yasui, Yoshihide Fujiyama.   

Abstract

BACKGROUND AND AIMS: Short-chain fatty acids (SCFAs), such as acetate, propionate and butyrate, are the major by-product of bacterial fermentation of dietary fiber in the colon. In this report, we investigated how SCFAs modulate matrix metalloproteinase (MMP) secretion from human colonic subepithelial myofibroblasts (SEMFs).
MATERIALS AND METHODS: SEMFs were identified by expression of alpha-smooth muscle actin and vimentin. Cytokine-induced MMP-1 and MMP-3 levels were determined by enzyme-linked immunosorbent assay. Cytokine-induced MMP mRNA expression was analyzed by RT-PCR and real-time PCR methods.
RESULTS: Acetate had no effect on MMP secretion. Propionate and butyrate significantly attenuated IL-1 beta- and TNF-alpha-induced MMP-1 and MMP-3 secretion. Similar responses were also observed at the mRNA levels. Propionate and butyrate did not modulate IL-1 beta- and TNF-alpha-induced activation of mitogen-activated protein kinases (MAPKs), which play a crucial role in MMP induction. Trichostatin A, a histone-deacetylase inhibitor, reduced IL-1 beta-induced MMP-1 and MMP-3 mRNA expression, and suppressed TNF-alpha-induced MMP-3 mRNA expression.
CONCLUSION: SCFAs play an anti-inflammatory role through suppression of MMP secretion in the colon. Inhibitory effects of SCFAs on MMP secretion might be associated with their action of histone hyperacetylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18629644     DOI: 10.1007/s10620-008-0348-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

2.  Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.

Authors:  E Louis; C Ribbens; A Godon; D Franchimont; D De Groote; N Hardy; J Boniver; J Belaiche; M Malaise
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 3.  Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response.

Authors:  Akira Andoh; Shigeki Bamba; Yoshihide Fujiyama; Mairi Brittan; Nicholas A Wright
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

4.  Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells.

Authors:  A Andoh; Y Fujiyama; K Hata; Y Araki; H Takaya; M Shimada; T Bamba
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

5.  Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes.

Authors:  Abdelhamid Liacini; Judith Sylvester; Wen Qing Li; Muhammad Zafarullah
Journal:  Matrix Biol       Date:  2002-04       Impact factor: 11.583

6.  Mechanisms of tissue damage in inflammatory bowel disease.

Authors:  F Pallone; G Monteleone
Journal:  Curr Opin Gastroenterol       Date:  2001-07       Impact factor: 3.287

7.  Butyrate blocks interferon-gamma-inducible protein-10 release in human intestinal subepithelial myofibroblasts.

Authors:  Osamu Inatomi; Akira Andoh; Ken-Ichi Kitamura; Hirofumi Yasui; Zhuobin Zhang; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2005-05       Impact factor: 7.527

Review 8.  Interaction between interleukin-17-producing CD4+ T cells and colonic subepithelial myofibroblasts: what are they doing in mucosal inflammation?

Authors:  Akira Andoh; Atsuhiro Ogawa; Shigeki Bamba; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

9.  Intestinal subepithelial myofibroblasts in inflammatory bowel diseases.

Authors:  Akira Andoh; Sanae Fujino; Takafumi Okuno; Yoshihide Fujiyama; Tadao Bamba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

10.  Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment.

Authors:  Konrad A Bode; Kate Schroder; David A Hume; Timothy Ravasi; Klaus Heeg; Matthew J Sweet; Alexander H Dalpke
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

View more
  8 in total

1.  Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB pathway in RAW264.7 cells.

Authors:  Tengfei Liu; Jing Li; Yuxin Liu; Nan Xiao; Haitao Suo; Kun Xie; Chunliu Yang; Chen Wu
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

2.  Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis.

Authors:  Akira Andoh; Hirotsugu Imaeda; Tomoki Aomatsu; Osamu Inatomi; Shigeki Bamba; Masaya Sasaki; Yasuharu Saito; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2011-01-21       Impact factor: 7.527

3.  Butyrate stimulates IL-32alpha expression in human intestinal epithelial cell lines.

Authors:  Ayako Kobori; Shigeki Bamba; Hirotsugu Imaeda; Hiromitsu Ban; Tomoyuki Tsujikawa; Yasuharu Saito; Yoshihide Fujiyama; Akira Andoh
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

Review 4.  Immunological roles of intestinal mesenchymal cells.

Authors:  Robert J Nibbs; Kathy D McCoy; Allan Mcl Mowat; Carolyn A Thomson
Journal:  Immunology       Date:  2020-04-20       Impact factor: 7.397

5.  Suppression of fibrosis in human pterygium fibroblasts by butyrate and phenylbutyrate.

Authors:  Yuka Koga; Noriaki Maeshige; Hiroto Tabuchi; Mikiko Uemura; Michiko Aoyama-Ishikawa; Makoto Miyoshi; Chikako Katakami; Makoto Usami
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

6.  Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice.

Authors:  Fuzheng Tao; Xi Xing; Jiannong Wu; Ronglin Jiang
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

Review 7.  Fatty Acids as a Tool to Boost Cancer Immunotherapy Efficacy.

Authors:  Annemarie J F Westheim; Lara M Stoffels; Ludwig J Dubois; Jeroen van Bergenhenegouwen; Ardy van Helvoort; Ramon C J Langen; Ronit Shiri-Sverdlov; Jan Theys
Journal:  Front Nutr       Date:  2022-06-23

8.  Effect of Clostridium butyricum and Butyrate on Intestinal Barrier Functions: Study of a Rat Model of Severe Acute Pancreatitis With Intra-Abdominal Hypertension.

Authors:  Han-Bing Zhao; Lin Jia; Qing-Qing Yan; Qi Deng; Bo Wei
Journal:  Front Physiol       Date:  2020-10-29       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.